MENU
OTLC
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Oncotelic Therapeutics (OTLC) Ownership - Who owns Oncotelic Therapeutics?
Profile
Industry
N/A
Address
29397 Agoura Road
Phone
+1 650 635-7000
Employees
22
Web
https://www.oncotelic.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.26M
P/E Ratio
N/A
Total Cash
72.22K
Projected Growth
N/A
Total Debt
12.6M
Revenue
70K
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
OTLC
Capitalization
10.3M
P/E Ratio
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash
72.2K
Total Cash/Share
0.00
Total Debt
12.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
70K
ROE
N/A
Book Value
12.2M
P/B Ratio
1.24
Cash Flow
N/A
Earnings
-0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.07M
Current Ratio
0.01
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-659.92K
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-4.13
Shares Held By Institutions
0
Shares Outstanding - Current
407M
Total Liabilities
18.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-34.144
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
29397 Agoura Road
Phone
+1 650 635-7000
Employees
22
Web
https://www.oncotelic.com